Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

References for PMC Articles for PubMed (Select 21976639)

1.

Characterization of indels in poxvirus genomes.

Coulson D, Upton C.

Virus Genes. 2011 Apr;42(2):171-7. doi: 10.1007/s11262-010-0560-x. Epub 2010 Dec 14.

PMID:
21153876
2.

RDP3: a flexible and fast computer program for analyzing recombination.

Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P.

Bioinformatics. 2010 Oct 1;26(19):2462-3. doi: 10.1093/bioinformatics/btq467. Epub 2010 Aug 26.

3.

Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.

Gammon DB, Gowrishankar B, Duraffour S, Andrei G, Upton C, Evans DH.

PLoS Pathog. 2010 Jul 8;6(7):e1000984. doi: 10.1371/journal.ppat.1000984.

4.

Clinical signs, diagnosis, and case reports of Vaccinia virus infections.

Silva DC, Moreira-Silva EA, Gomes Jde A, Fonseca FG, Correa-Oliveira R.

Braz J Infect Dis. 2010 Mar-Apr;14(2):129-34.

5.

Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing.

Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B.

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11513-8. doi: 10.1073/pnas.1006594107. Epub 2010 Jun 7.

6.

Zoonotic infections of buffalopox in India.

Bhanuprakash V, Venkatesan G, Balamurugan V, Hosamani M, Yogisharadhya R, Gandhale P, Reddy KV, Damle AS, Kher HN, Chandel BS, Chauhan HC, Singh RK.

Zoonoses Public Health. 2010 Dec;57(7-8):e149-55. doi: 10.1111/j.1863-2378.2009.01314.x.

PMID:
20042058
7.

Vaccinia virus particles mix inefficiently, and in a way that would restrict viral recombination, in coinfected cells.

Lin YC, Evans DH.

J Virol. 2010 Mar;84(5):2432-43. doi: 10.1128/JVI.01998-09. Epub 2009 Dec 23.

8.

FURTHER STUDIES OF THE INFECTIOUS UNIT OF VACCINIA.

Parker RF, Bronson LH, Green RH.

J Exp Med. 1941 Aug 31;74(3):263-81.

9.

Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.

Wyatt LS, Earl PL, Xiao W, Americo JL, Cotter CA, Vogt J, Moss B.

J Virol. 2009 Jul;83(14):7176-84. doi: 10.1128/JVI.00687-09. Epub 2009 May 6.

10.

Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.

Frey SE, Newman FK, Kennedy JS, Ennis F, Abate G, Hoft DF, Monath TP.

Vaccine. 2009 Mar 4;27(10):1637-44. doi: 10.1016/j.vaccine.2008.11.079. Epub 2008 Dec 9.

PMID:
19071184
11.

Phenotypic and genetic diversity of the traditional Lister smallpox vaccine.

Garcel A, Perino J, Crance JM, Drillien R, Garin D, Favier AL.

Vaccine. 2009 Jan 29;27(5):708-17. doi: 10.1016/j.vaccine.2008.11.063. Epub 2008 Dec 6.

PMID:
19059294
12.

ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.

Greenberg RN, Kennedy JS.

Expert Opin Investig Drugs. 2008 Apr;17(4):555-64. doi: 10.1517/13543784.17.4.555 . Review.

PMID:
18363519
13.

Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3.

Osborne JD, Da Silva M, Frace AM, Sammons SA, Olsen-Rasmussen M, Upton C, Buller RM, Chen N, Feng Z, Roper RL, Liu J, Pougatcheva S, Chen W, Wohlhueter RM, Esposito JJ.

Vaccine. 2007 Dec 17;25(52):8807-32. Epub 2007 Nov 8.

PMID:
18037545
14.

Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complication.

Li G, Chen N, Feng Z, Buller RM, Osborne J, Harms T, Damon I, Upton C, Esteban DJ.

Virol J. 2006 Oct 25;3:88.

15.

Genome of horsepox virus.

Tulman ER, Delhon G, Afonso CL, Lu Z, Zsak L, Sandybaev NT, Kerembekova UZ, Zaitsev VL, Kutish GF, Rock DL.

J Virol. 2006 Sep;80(18):9244-58.

16.

Frequency of adverse events after vaccination with different vaccinia strains.

Kretzschmar M, Wallinga J, Teunis P, Xing S, Mikolajczyk R.

PLoS Med. 2006 Aug;3(8):e272. Erratum in: PLoS Med. 2006 Oct;3(10):e429.

17.
18.

An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.

Morikawa S, Sakiyama T, Hasegawa H, Saijo M, Maeda A, Kurane I, Maeno G, Kimura J, Hirama C, Yoshida T, Asahi-Ozaki Y, Sata T, Kurata T, Kojima A.

J Virol. 2005 Sep;79(18):11873-91.

19.

Poxvirus Bioinformatics Resource Center: a comprehensive Poxviridae informational and analytical resource.

Lefkowitz EJ, Upton C, Changayil SS, Buck C, Traktman P, Buller RM.

Nucleic Acids Res. 2005 Jan 1;33(Database issue):D311-6.

20.

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Monath TP, Caldwell JR, Mundt W, Fusco J, Johnson CS, Buller M, Liu J, Gardner B, Downing G, Blum PS, Kemp T, Nichols R, Weltzin R.

Int J Infect Dis. 2004 Oct;8 Suppl 2:S31-44. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk